Recruiting
Phase 2
Phase 3

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

Sponsor:

Dynogen Pharmaceuticals

Code:

NCT00547469

Conditions

Irritable Bowel Syndrome

Eligibility Criteria

Sex: Female

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

DDP733

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information